Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application

Published:2020-05-27 Issue:20 Volume:63 Page:11368-11396
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Yuan Xinrui¹²,Bu Hong¹,Zhou Jinpei³^ORCID,Yang Chao-Yie²^ORCID,Zhang Huibin¹

Affiliation:

1. Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China

2. Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States

3. Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China

Funder

Ministry of Science and Technology of the People's Republic of China

Natural Science Foundation of Jiangsu Province

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c00249

Reference185 articles.

1. Tyrosine phosphorylation: thirty years and counting

2. Protein tyrosine phosphatases: from genes, to function, to disease

3. Protein tyrosine phosphatases: prospects for therapeutics

4. Inside the human cancer tyrosine phosphatome

5. Challenges and Opportunities in the Development of Protein Phosphatase-Directed Therapeutics

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphopeptide binding to the N-SH2 domain of tyrosine phosphatase SHP2 correlates with the unzipping of its central β-sheet;Computational and Structural Biotechnology Journal;2024-12

2. Star wars against leukemia: attacking the clones;Leukemia;2024-09-02

3. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

4. Advances in SHP2 tunnel allosteric inhibitors and bifunctional molecules;European Journal of Medicinal Chemistry;2024-09

5. Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder and therapy related acute myeloid leukemia;Leukemia Research;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3